Financials IRIDEX Corporation

Stocks

IRIX

US4626841013

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-25 EDT			5-day change	1st Jan Change
1.180 ^USD	-0.84%		+4.42%	+3.51%

05-19	IRIDEX Corporation, Q1 2026 Earnings Call, May 19, 2026
05-19	IRIDEX Corporation Reports Earnings Results for the First Quarter Ended April 04, 2026	CI

Projected Income Statement: IRIDEX Corporation

Fiscal Period: January	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	53.9	56.97	51.87	-	52.68	53	56.77	60.09
Change	-	5.69%	-8.96%	-	-	0.62%	7.11%	5.86%
EBITDA ¹	-6.73	-7.057	-7.259	-	1.122	2.457	3.641	4.559
Change	-	-4.86%	-2.86%	-	-	118.98%	48.19%	25.21%
EBIT ¹	-7.533	-7.542	-10.01	-	-2.571	-0.265	0.801	1.737
Change	-	-0.12%	-32.68%	-	-	89.69%	402.26%	116.85%
Interest Paid ¹	-	0.06	-	-	-1.809	-0.442	-0.4	-0.2
Earnings before Tax (EBT) ¹	-5.185	-7.482	-9.48	-	-4.38	-0.707	0.401	1.537
Change	-	-44.3%	-26.7%	-	-	83.86%	156.72%	283.29%
Net income ¹	-5.225	-7.547	-9.57	-8.91	-4.437	-0.795	0.361	1.383
Change	-	-44.44%	-26.81%	6.9%	50.2%	82.08%	145.41%	283.1%
Announcement Date	3/10/22	3/9/23	3/26/24	3/27/25	3/26/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: January	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	13.43	13.26	15.25	13.39	13.76	14.64	15.2	13.71	12.86	12.85	12.46	11.76	12.63	-	-	14.72	11.8	13.59	12.98	14.64
Change	-	-1.21%	15%	-12.24%	2.75%	6.4%	3.83%	-9.8%	-6.21%	-0.04%	-3.05%	-5.59%	7.4%	-	-	-	-19.87%	15.15%	-4.49%	12.8%
EBITDA ¹	-	-	-2.181	-1.774	-1.707	-1.207	-1.264	-1.727	-2.264	-1.212	-2.056	-2.726	-2.08	-	-	0.817	0.259	0.576	0.554	1.068
Change	-	-	-	18.66%	3.78%	29.29%	-4.72%	-36.63%	-31.09%	46.47%	-69.64%	-32.59%	23.7%	-	-	-	-68.3%	122.39%	-3.82%	92.78%
EBIT ¹	-1.138	-2.157	-2.397	-2.277	-2.16	-1.695	-1.41	-2.344	-2.894	-1.688	-3.081	-3.293	-2.638	-	-	-0.015	-0.324	-0.137	-0.159	0.355
Change	-	-89.54%	-11.13%	5.01%	5.14%	21.53%	16.81%	-66.24%	-23.46%	41.67%	-82.52%	-6.88%	19.89%	-	-	-	-2,060%	57.72%	-16.06%	323.27%
Charge d'intérêts ¹	-	-	-	-	-	-	-	0.266	0.138	-	-	-	-	-	-	-0.149	-0.142	-0.1	-0.1	-0.1
Earnings before Tax (EBT) ¹	1.401	-2.157	-2.427	-2.371	-2.224	-1.753	-1.134	-2.078	-2.756	-1.746	-2.9	-3.426	-2.66	-	-	-0.164	-0.466	-0.237	-0.259	0.255
Change	-	-253.96%	-12.52%	2.31%	6.2%	21.18%	35.31%	-83.25%	-32.63%	36.65%	-66.09%	-18.14%	22.36%	-	-	-	-184.15%	49.14%	-9.28%	198.46%
Net income ¹	1.393	-2.165	-2.443	-2.391	-2.241	-1.767	-1.148	-2.09	-2.766	-1.754	-2.96	-3.464	-2.679	-1.933	-1.573	-0.184	-0.524	-0.247	-0.269	0.245
Change	-	-255.42%	-12.84%	2.13%	6.27%	21.15%	35.03%	-82.06%	-32.34%	36.59%	-68.76%	-17.03%	22.66%	27.85%	18.62%	88.3%	-184.78%	52.86%	-8.91%	191.08%
Announcement Date	8/12/21	11/11/21	3/10/22	5/12/22	8/15/22	11/10/22	3/9/23	5/11/23	8/10/23	11/14/23	3/26/24	5/14/24	8/8/24	11/12/24	11/11/25	3/26/26	5/19/26	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: IRIDEX Corporation

Fiscal Period: January	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	3/10/22	3/9/23	3/26/24	3/27/25	3/26/26	-	-	-

Estimates

Cash Flow Forecast: IRIDEX Corporation

Fiscal Period: January	2020	2021	2022	2023	2024	2025
CAPEX ¹	0.097	0.213	0.286	0.109	0.013	0.143
Change	-	119.59%	34.27%	-61.89%	-88.07%	1,000%
Free Cash Flow (FCF) ¹	-0.7644	-1.462	-5.741	-0.6904	-1.214	1.528
Change	-	-91.28%	-292.63%	87.97%	-75.81%	225.9%
Announcement Date	3/23/21	3/15/22	3/9/23	3/29/24	3/27/25	4/2/26

¹USD in Million

Estimates

Forecast Financial Ratios: IRIDEX Corporation

Fiscal Period: January	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-12.49%	-12.39%	-13.99%	-	2.13%	4.64%	6.41%	7.59%
EBIT Margin (%)	-	-13.98%	-13.24%	-19.29%	-	-4.88%	-0.5%	1.41%	2.89%
EBT Margin (%)	-	-9.62%	-13.13%	-18.28%	-	-8.32%	-1.33%	0.71%	2.56%
Net margin (%)	-	-9.69%	-13.25%	-18.45%	-	-8.42%	-1.5%	0.64%	2.3%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-	-
Profitability
ROA	-13.11%	-12.28%	-10.36%	-16.3%	-16.32%	-5.51%	-	-	-
ROE	-31.59%	-25.7%	-37.24%	-71.54%	-153.37%	-126.43%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
EPS ¹	-	-0.34	-0.47	-0.59	-0.54	-0.26	-0.05	0.02	0.07
Change	-	-	-38.24%	-25.53%	8.47%	51.85%	80.77%	140%	250%
Nbr of stocks (in thousands)	-	15,866	15,990	16,248	16,636	17,190	17,407	17,407	17,407
Announcement Date	-	3/10/22	3/9/23	3/26/24	3/27/25	3/26/26	-	-	-